Foghorn Therapeutics (NASDAQ:FHTX) Earns “Buy” Rating from HC Wainwright
Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $13.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 212.50% from the company’s previous close. […]
Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $13.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 212.50% from the company’s previous close. […]
-logo-1200x675.png?v=20221109115655&w=240&h=240&zc=2){kind=logo}
